New Hampshire 2025 Regular Session

New Hampshire Senate Bill SB119

Introduced
1/22/25  
Refer
1/22/25  
Report Pass
2/7/25  
Report Pass
3/13/25  
Engrossed
3/28/25  
Refer
3/28/25  
Report Pass
5/7/25  

Caption

Relative to Medicaid pharmaceutical services and relative to standing orders for Ivermectin.

Companion Bills

No companion bills found.

Previously Filed As

NH SB555

Relative to receipt of pharmaceutical rebates by insurers and pharmacy benefits managers.

NH SB50

Relative to pharmaceutical drug take-back programs.

NH SB440

Relative to the board of optometry and the regulation of optometry.

NH HB2

Relative to state fees, funds, revenues, and expenditures.

NH HB655

Relative to the office of professional licensure and certification.

NH SB175

Relative to Medicaid coverage for mothers.

NH HB1095

Relative to the administration of occupational boards by the office of professional licensure and certification.

NH HB554

Relative to treatment alternatives to opioids.

NH HB554

Relative to treatment alternatives to opioids.

NH SB178

Relative to certain specialty formulas under Medicaid.

Similar Bills

LA HB1180

Provides for a feasibility study concerning a pharmaceutical and therapeutics committee for Medicaid managed care

AR HB1531

To Prohibit Pharmaceutical Manufacturers From Restricting Or Limiting Prescription Medications To A Limited Distribution Network Of Out-of-state Pharmacies.

CT SB00068

An Act Concerning The Department Of Social Services' Recommended Changes To The Medical Assistance And Pharmacy Statutes.

LA SB117

Provides for the Medicaid Pharmaceutical and Therapeutics Committee.

LA HB233

Prohibits the La. Medicaid Program from providing coverage for brand name drugs in certain instances (OR DECREASE SG RV See Note)

LA HB393

Provides relative to prescription drug benefits of certain managed care organizations participating in the La. Medicaid coordinated care network program (RE1 INCREASE GF EX See Note)

KY HB695

AN ACT relating to the Medicaid program and declaring an emergency.

HI HCR186

Urging The Governor, Department Of Human Services, And Department Of Health To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.